Champions Oncology

CSBRNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$72.108 M

$5.19 +0.00%

Close of 7 Aug 2026

Revenue

$59.4M

#2685 by revenue

Earnings

-$1.18M

Loss-making

Shares outstanding

13,893,569

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#117Atara BiotherapeuticsATRA$76.1M
#118LeonaBioLONA$72.1M
#119Champions OncologyCSBR$72.1M
#120Eloxx PharmaceuticalsELOX$70.9M
#121ImageneBioIMA$64.6M

Where these numbers come from

Share counts and financials for Champions Oncology are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.